サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1750817

北米と欧州の医薬品安定保管サービス市場規模、シェア、動向分析レポート：サービス別、分子別、国別、セグメント別予測、2025年～2030年

North America And Europe Pharmaceutical Stability & Storage Services Market Size, Share & Trends Analysis Report By Services (Stability, Storage), By Molecule (Large Molecule, Small Molecule), By Country, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
北米と欧州の医薬品安定保管サービス市場規模、シェア、動向分析レポート：サービス別、分子別、国別、セグメント別予測、2025年～2030年
出版日: 2025年05月05日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米と欧州の医薬品安定保管サービス市場の成長と動向：

北米と欧州の医薬品安定保管サービス市場は、2030年までに19億2,000万米ドルに達すると予測されています。

Grand View Research, Inc.の最新レポートによると、予測期間中にCAGR 6.4％で拡大すると予測されています。厳しい規制要件、研究開発投資の増加、臨床試験の世界化は、市場成長を促進する主な要因の一部です。

バイオシミラーに対する需要の高まりは、市場の進展を促進すると予想されます。近年、バイオシミラーの承認率は著しく向上しています。2020年に発表されたAmgen Biosimilars Trend Reportによると、米国におけるバイオシミラーの承認件数は前年から65%増加しました。2023年現在、米国では41品目、EUでは70品目以上のバイオシミラーが承認されています。バイオシミラーの承認拡大が市場にプラスの影響を与える可能性が高いです。

さらに、これらの地域では個別化医療へのシフトが進んでいるため、個別化治療の特徴に合わせた安定性試験が必要となり、患者固有の治療が効果を維持できるようになっています。自動化、高度なデータ分析、リアルタイムモニタリング技術の統合、安定性試験プロセスの合理化、意思決定の迅速化など、技術革新も状況を一変させています。これらの進歩は、業務の有効性を高め、製品の挙動に関する洞察を即座に提供し、市場の成長をさらに後押ししています。

さらに、北米と欧州の製薬業界は、安定性試験と保管のための最新設備を備えた高度に発達したインフラの恩恵を受けており、温度に敏感な製品を含む最新の医薬品の複雑な要件をサポートしています。また、新薬のパイプラインが増加していること、特に生物製剤や特殊医薬品など、独自の保管ニーズがあり保存期間が短い医薬品が増加していることも、高度な安定保管ソリューションの需要を後押ししています。

北米と欧州の医薬品安定保管サービス市場レポートハイライト：

  • 安定性試験分野がサービス分野を独占。2024年の売上シェアは73.8%で最大。バイオ医薬品と個別化医薬品の需要の急速な伸びが、医薬品安定性サービスの進歩を促進しています。
  • 発展途上地域におけるジェネリック医薬品やバイオシミラー医薬品への注目の高まりにより、保管分野は予測期間中にCAGR 5.8%で成長すると予想されます。
  • 低分子医薬品分野が市場を独占し、2024年の売上高シェアは79.4%で最大です。予測、構造ベースの設計、イメージング、自動化、人工知能、機械学習における最近の進歩は、低分子のリード最適化のペースと成功率を高める重要な促進要因となっています。
  • 高分子セグメントは、2025年から2030年にかけて大きなCAGRで成長すると予想されています。これは、タンパク質、核酸、炭水化物、生体細胞、組織などの大型分子の採用が増加しているためです。
  • 北米は医薬品安定保管サービス市場を独占しています。生物製剤や個別化医薬品を含む複雑な医薬品のパイプラインが増加しており、専門的な安定性試験や管理された保管ソリューションが必要とされ、市場拡大に拍車をかけているためです。
  • 欧州も今後数年間で大きな市場シェアを占めると予想されます。英国は医薬品分野の研究開発に力を入れています。企業が新薬の開発や臨床試験の実施に投資する中、こうした活動をサポートする安定性試験や保管サービスへの需要が高まっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 北米と欧州の医薬品安定保管サービス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 北米と欧州の医薬品安定保管サービス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 北米と欧州の医薬品安定保管サービス市場：サービス別分析

  • サービスセグメントダッシュボード
  • 医薬品の安定保管サービス市場：サービス変動分析
  • 北米と欧州の医薬品安定保管サービス市場規模と動向分析（サービス別、2018～2030年）
  • 安定性試験
  • ストレージ

第5章 北米と欧州の医薬品安定保管サービス市場：分子別分析

  • 分子セグメントダッシュボード
  • 医薬品の安定保管サービス市場：分子別　変動分析
  • 北米と欧州の医薬品安定保管サービス市場の規模と動向分析（分子別、2018～2030年）
  • 小分子
  • 大分子

第6章 北米と欧州の医薬品安定保管サービス市場：国別分析

  • 地域市場ダッシュボード
  • 地域別市場シェア分析、2024年および2030年
  • 北米と欧州の医薬品安定保管サービス市場：地域別
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • Key Company Heat Map Analysis, 2024
  • 企業プロファイル
    • Eurofins Scientific
    • Intertek Group plc
    • Lucideon Limited
    • Element Materials Technology
    • Q1 Scientific
    • Reading Scientific Services Ltd.
    • Catalent, Inc.
    • Quotient Sciences
    • Recipharm AB
    • Almac Group
    • Alcami Corporation
    • BioLife Solutions, Inc.
    • Sampled（Roylance Stability Storage Limited）
    • Precision Stability Storage
    • Broughton
図表

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 North America and Europe Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 3 North America and Europe Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 4 North America and Europe Pharmaceutical Stability and Storage Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Pharmaceutical Stability and Storage Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 8 U.S. Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 9 U.S. Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 10 Canada Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 11 Canada Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 12 Mexico Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 13 Mexico Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 14 Europe Pharmaceutical Stability and Storage Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 15 Europe Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 16 Europe Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 17 Germany Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 18 Germany Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 19 UK Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 20 UK Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 21 France Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 22 France Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 23 Italy Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 24 Italy Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 25 Spain Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 26 Spain Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 27 Denmark Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 28 Denmark Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 29 Sweden Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 30 Sweden Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 31 Norway Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 32 Norway Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 North America and Europe Pharmaceutical Stability and Storage Services Market: Market Outlook
  • Fig. 10 North America and Europe Pharmaceutical Stability and Storage Services Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 North America and Europe Pharmaceutical Stability and Storage Services Market Driver Impact
  • Fig. 16 North America and Europe Pharmaceutical Stability and Storage Services Market Restraint Impact
  • Fig. 17 North America and Europe Pharmaceutical Stability and Storage Services Market Strategic Initiatives Analysis
  • Fig. 18 North America and Europe Pharmaceutical Stability and Storage Services Market: Service Movement Analysis
  • Fig. 19 North America and Europe Pharmaceutical Stability and Storage Services Market: Service Outlook and Key Takeaways
  • Fig. 20 Stability Testing Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Storage Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 North America and Europe Pharmaceutical Stability and Storage Services Market: Molecule Movement Analysis
  • Fig. 23 North America and Europe Pharmaceutical Stability and Storage Services Market: Molecule Outlook and Key Takeaways
  • Fig. 24 Small Molecule Market Estimates and Forecasts, 2018 - 2030
  • Fig. 25 Large Molecule Market Estimates and Forecasts, 2018 - 2030
  • Fig. 26 North America and Europe Pharmaceutical Stability and Storage Services Market: Regional Outlook and Key Takeaways
  • Fig. 27 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 28 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 29 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 30 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 31 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 32 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 33 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Norway Market Estimates and Forecasts, 2018 - 2030
目次
Product Code: GVR-4-68040-123-7

North America And Europe Pharmaceutical Stability & Storage Services Market Growth & Trends:

The North America and Europe pharmaceutical stability & storage services market is anticipated to reach USD 1.92 billion by 2030. It is anticipated to expand at a CAGR of 6.4% during the forecast period, according to a new report by Grand View Research, Inc. Stringent regulatory requirements, increasing R&D investments, and globalization of clinical trials are some of the major factors driving market growth.

The rising demand for biosimilars is expected to drive market advancement. In recent years, the approval rate for biosimilars has significantly improved. As per the Amgen Biosimilars Trend Report published in 2020, the number of biosimilar approvals in the U.S. increased by 65% since the preceding year. As of 2023, 41 biosimilars were approved in the U.S., and over 70 were approved in the EU. The growing approval of biosimilars is likely to impact the market positively.

In addition, the shift toward personalized medicine in these regions necessitates stability testing tailored to the distinct features of individualized treatments, ensuring that patient-specific therapies remain effective. Technological innovations have also transformed the landscape, integrating automation, advanced data analytics, and real-time monitoring technologies, streamlining stability testing processes, and accelerating decision-making. These advancements enhance operational effectiveness and provide immediate insights into product behavior, further propelling market growth.

Furthermore, the pharmaceutical industries in North America and Europe benefit from highly developed infrastructure equipped with state-of-the-art facilities for stability testing and storage, supporting the complex requirements of modern pharmaceuticals, including temperature-sensitive products. The increasing pipeline of new drugs, especially biologics and specialty medicines with unique storage needs and shorter shelf lives, also drives demand for advanced stability and storage solutions.

North America And Europe Pharmaceutical Stability & Storage Services Market Report Highlights:

  • The stability testing segment dominated the service segment. It held the largest revenue share of 73.8% in 2024. The rapid growth in the demand for biopharmaceuticals and personalized medicines is driving advancements in pharmaceutical stability services
  • The storage segment is expected to grow at a CAGR of 5.8% over the forecast period, owing to the increasing focus on generics and biosimilars in developing regions.
  • The small molecules segment dominated the market, with the largest revenue share of 79.4% in 2024. Recent advances in forecasting, structure-based design, imaging, automation, artificial intelligence, and machine learning have become critical facilitators for increasing small molecules lead optimization's pace and success rates
  • The large molecules segment is expected to grow at a significant CAGR from 2025 to 2030. This is due to the increasing adoption of large molecules such as proteins, nucleic acids, carbohydrates, living cells, and tissues.
  • North America dominated the pharmaceutical stability & storage services market. It held the largest revenue share in 2024, driven by the growing pipeline of complex drugs, including biologics and personalized medicines, necessitating specialized stability testing and controlled storage solutions, fueling market expansion.
  • Europe is also expected to account for a significant market share in the coming years. The UK has a strong emphasis on R&D in the pharmaceutical sector. As companies invest in developing new drugs and conducting clinical trials, there is an increased demand for stability testing and storage services to support these activities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Molecule
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Service Outlook
    • 2.2.2. Molecule Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. North America and Europe Pharmaceutical Stability and Storage Services Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. North America and Europe Pharmaceutical Stability and Storage Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. North America and Europe Pharmaceutical Stability and Storage Services Market: Service Business Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Pharmaceutical Stability and Storage Services Market: Service Movement Analysis
  • 4.3. North America and Europe Pharmaceutical Stability and Storage Services Market Size & Trend Analysis, By Service, 2018 to 2030 (USD Million)
  • 4.4. Stability Testing
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Drug Substance
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Stability Indicating Method Validation
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Accelerated Stability Testing
      • 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Photo Stability Testing
      • 4.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Other Stability Testing Methods
      • 4.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Storage
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Cold
      • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Non-Cold
      • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. North America and Europe Pharmaceutical Stability and Storage Services Market: Molecule Business Analysis

  • 5.1. Molecule Segment Dashboard
  • 5.2. Pharmaceutical Stability and Storage Services Market: Molecule Movement Analysis
  • 5.3. North America and Europe Pharmaceutical Stability and Storage Services Market Size & Trend Analysis, By Molecule, 2018 to 2030 (USD Million)
  • 5.4. Small Molecule
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Research Products
      • 5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Commercial Products
      • 5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Large Molecule
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Research Products
      • 5.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Commercial Products
      • 5.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. North America and Europe Pharmaceutical Stability and Storage Services Market: Country Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. North America and Europe Pharmaceutical Stability and Storage Services Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.1.3. Competitive Scenario
      • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Germany
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.1.3. Competitive Scenario
      • 6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.8.3. Competitive Scenario
      • 6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key Company Heat Map Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Eurofins Scientific
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Intertek Group plc
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Lucideon Limited
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Element Materials Technology
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Q1 Scientific
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Reading Scientific Services Ltd.
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Catalent, Inc.
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Quotient Sciences
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Recipharm AB
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Almac Group
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Alcami Corporation
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. BioLife Solutions, Inc.
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. Sampled (Roylance Stability Storage Limited)
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic Initiatives
    • 7.4.14. Precision Stability Storage
      • 7.4.14.1. Company Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic Initiatives
    • 7.4.15. Broughton
      • 7.4.15.1. Company Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Strategic Initiatives